Table 2.
Baseline Demographics of Patients With Cardiac Sarcoidosis
| Total (n=28) | Immunosuppression Discontinued (n=9) | No Immunosuppression Discontinuation (n=19) | |
|---|---|---|---|
| Demographics | |||
| Age, y | 52.2 | 51.3 | 53.0 |
| Women | 12 (42.8%) | 6 (66.7%) | 6 (31.6%) |
| Body mass index, kg/m2 | 28.8 | 27.4 | 21.1 |
| Medical history | |||
| Hypertension | 5 (17.8%) | 1 (11.1%) | 4 (21.1%) |
| Hyperlipidemia | 3 (10.7%) | 1 (11.1%) | 2 (10.5%) |
| Diabetes mellitus | 2 (3.6%) | 0 | 2 (10.5%) |
| Coronary artery disease | 1 (3.6%) | 0 | 1 (5.3%) |
| PPM/ICD | 26 (92.9%) | 9 (100%) | 17 (89.5%) |
| Extracardiac sarcoidosis | 26 (92.9%) | 9 (100%) | 17 (89.5%) |
| Lung | 21 (72.4%) | 5 (55.6%) | 16 (84.2%) |
| Spleen | 5 (17.8%) | 1 (11.1%) | 4 (21.1%) |
| Lymph nodes | 18 (64.3%) | 4 (44.4%) | 14 (73.7%) |
| ECG | |||
| LBBB | 3 (10.7%) | 1 (11.1%) | 2 (10.5%) |
| RBBB | 12 (42.9%) | 5 (55.6%) | 7 (36.8%) |
| 1st degree atrioventricular block | 11 (39.3%) | 3 (33.3%) | 8 (42.1%) |
| Frequent PVCs | 16 (57.1%) | 6 (66.7%) | 10 (52.6%) |
| Non‐sustained VT | 10 (35.7%) | 3 (33.3%) | 7 (36.8%) |
| Prevalent cardiac manifestations | |||
| Atrial arrhythmia | 8 (28.6%) | 4 (44.4%) | 4 (21.1%) |
| High‐grade atrioventricular block | 11 (39.2%) | 3 (33.3%) | 8 (42.1%) |
| Sudden cardiac arrest | 4 (14.3%) | 2 (22.2%) | 2 (10.5%) |
| Heart failure | 11 (39.3%) | 4 (44.4%) | 7 (36.8%) |
| Sustained VT or VF | 18 (64.3%) | 6 (66.7%) | 12 (63.2%) |
ICD indicates implanted cardioverter defibrillator; LBBB, left bundle branch block; PPM, permanent pacemaker; RBBB, right bundle branch block; VF, ventricular fibrillation; VT, ventricular tachycardia; PVCs, premature ventricular contractions.